Wrap Text
Director's & PDMR dealings
Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
("PHP" or the "Company")
Director's & PDMR dealings
On 5 March 2024, the remuneration committee of Primary Health Properties PLC (the "Company" or
"PHP") made the following awards of nil-cost options under the Company's 2021 Long-term Incentive
Plan ("LTIP") to a Director and Persons Discharging Managerial Responsibilities ("PDMR's").
Director Number of shares under option
Richard Howell 539,779
PDMR
David Bateman 348,137
Toby Newman 115,488
David Austin 131,109
The number of nil-cost options were calculated by reference to a price of £0.8962, being the average
of the closing middle market quotations for the Company's ordinary shares on 28 February 2024, 29
February 2024 and 1 March 2024.
The nil-cost options will normally vest on the third anniversary of grant, subject to the attainment of
performance conditions. The remuneration committee has the discretion to adjust the awards
downwards at vesting for malus reasons. Details of the operation of the LTIP are set out in the
Company's 2022 Report and Accounts.
Details of the transactions referenced above are included below in accordance with the under Article
19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name Richard Howell
2 Reason for notification
(a) Position/Status Chief Financial Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date: and (iv) each place where transactions
have been conducted
(a) Description of the financial instrument, type Ordinary shares of 12.5p
of instrument and identification code ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the
Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 539,779
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name David Bateman
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date: and (iv) each place where transactions
have been conducted
(a) Description of the financial instrument, type Ordinary shares of 12.5p
of instrument and identification code ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the
Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 348,137
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibility/person closely
associated
(a) Name Toby Newman
2 Reason for notification
(a) Position/Status Company Secretary & Chief Legal
Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date: and (iv) each place where transactions
have been conducted
(a) Description of the financial instrument, type Ordinary shares of 12.5p
of instrument and identification code ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the
Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 115,488
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name David Austin
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date: and (iv) each place where transactions
have been conducted
(a) Description of the financial instrument, type Ordinary shares of 12.5p
of instrument and identification code ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the
Company's ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 131,109
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 7 March 2024
(f) Place of transaction N/A
More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk
Further details:
Harry Hyman Steven Owen
Chief Executive Officer Chairman
Tel: +44 (0) 7973 344768 Tel: +44 (0) 203 8241 841
Richard Howell
Chief Financial Officer
Tel: +44 (0) 7766 072272
David Rydell / Stephanie Whitmore (Buchanan
Communications)
Tel: +44 (0) 20 7466 5066
The Company has a primary listing on the London Stock Exchange and a secondary listing on the
JSE Limited.
United Kingdom
8 March 2024
Sponsor: PSG Capital
Date: 08-03-2024 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.